The Business Case for Cannabis

The Business Case for Cannabis

The Business Case for Cannabis

Both consumer products manufacturer and retailers agree that cannabis products, including hemp-derived CBD, will impact the entire CPG marketplace. Some companies have already jumped into the CBD marketplace, while others are waiting for more guidance from the Food and Drug Administration before moving. But even companies that are sure they won’t be competing with their own cannabis products need to know how they’ll be impacted and what other opportunities sales of cannabis might create for them. Jessica Lukas, SVP of Commercial Development, BDS Analytics and Chris Von Der Linden, EVP, Market and Shopper Intelligence, talk about the spectrum of involvement, from first movers to those who can benefit just by being in the same retail space with cannabis products.
 

Listen Now